• 701 Citations
  • 13 h-Index
20022019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Haiying Cheng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles
Lung Neoplasms Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Biomarkers Medicine & Life Sciences
Squamous Cell Neoplasms Medicine & Life Sciences
Mutation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Publications 2002 2019

  • 701 Citations
  • 13 h-Index
  • 32 Article
  • 11 Review article
  • 1 Letter

Emerging drugs for EGFR-mutated non-small cell lung cancer

Sukrithan, V., Deng, L., Barbaro, A. & Cheng, H., Jan 2 2019, In : Expert Opinion on Emerging Drugs. 24, 1, p. 5-16 12 p.

Research output: Contribution to journalReview article

Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Protein-Tyrosine Kinases
Pharmaceutical Preparations
Standard of Care
Vulnerable Populations
Primary Care Physicians
Lung Neoplasms
Primary Health Care
Mortality

Mortality of lung cancer as a second primary malignancy: A population-based cohort study

Deng, L., Harðardottír, H., Song, H., Xiao, Z., Jiang, C., Wang, Q., Valdimarsdóttir, U., Cheng, H., Loo, B. W. & Lu, D., Jun 1 2019, In : Cancer Medicine. 8, 6, p. 3269-3277 9 p.

Research output: Contribution to journalArticle

Open Access
Second Primary Neoplasms
Lung Neoplasms
Cohort Studies
Lung
Mortality

Survival Disparities in Black Patients With EGFR-mutated Non–small-cell Lung Cancer

Cheng, H., Hosgood, H. D., Deng, L., Ye, K., Su, C., Sharma, J. N., Yang, Y., Halmos, B. & Perez-Soler, R., Jan 1 2019, (Accepted/In press) In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Lung Neoplasms
Survival
Weights and Measures
3 Citations (Scopus)

Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy

Rzepecki, A. K., Cheng, H. & McLellan, B. N., Sep 1 2018, In : Journal of the American Academy of Dermatology. 79, 3, p. 545-555 11 p.

Research output: Contribution to journalReview article

Biomarkers
Skin
Therapeutics
Phosphotransferases
Prospective Studies